Stay updated on Nivolumab vs Temozolomide in GBM Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Temozolomide in GBM Clinical Trial page.

Latest updates to the Nivolumab vs Temozolomide in GBM Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision: v3.6.5 replaces v3.6.4, indicating a newer page version. This update affects only the page's version metadata and does not modify the trial details or other visible content.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedThe revision tag on the page was updated from v3.6.3 to v3.6.4, indicating an internal update to the page. No substantive study information appears to be altered.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, representing a small update to the study record and related documentation.SummaryDifference0.0%

- Check53 days agoChange DetectedSoftware revision updated from v3.6.0 to v3.6.2, a minor version bump without changes to the study details or page content.SummaryDifference0.0%

- Check67 days agoChange DetectedThe study page now indicates recruitment has ended for participants. New help/navigation items were added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment heading was reformatted while the revision version was updated to v3.6.0.SummaryDifference0.2%

- Check74 days agoChange DetectedThe page’s revision tag was updated from v3.5.4 to v3.5.5, indicating a minor metadata update rather than a change to the study information.SummaryDifference0.0%

Stay in the know with updates to Nivolumab vs Temozolomide in GBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Temozolomide in GBM Clinical Trial page.